Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JD.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDAORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDAENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDAENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDANUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
JG.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JG.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.1.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.1.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JF.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JF.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used